Central sleep apnea after interrupting longterm acetazolamide therapy

Respiration Physiology

Volumn 112, Issue 1, 1998, Pages 59-70

  Verbraecken, J ^a   Willemen, M ^a   De Cock, W ^a   Coen, E ^a   Van de Heyning, P ^a   De Backer, W ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Mammals, humans; Pattern of breathing, sleep apnea; Pharmacological agents, acetazolamide; Sleep, central apnea, acetazolamide

Indexed keywords

ACETAZOLAMIDE;

ARTICLE; BREATHING PATTERN; CLINICAL ARTICLE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; GAS EXCHANGE; HUMAN; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; SLEEP APNEA SYNDROME; SLEEP STAGE;

ACETAZOLAMIDE; ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATION; SLEEP APNEA SYNDROMES;

EID: 0031748364     PISSN: 00345687     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5687(98)00010-3     Document Type: Article

References (29)

1. Bashir Y., Kann M., Stradling J.R. The effect of acetazolamide on hypercapnic and eucapnic/poikilocapnic hypoxic ventilatory responses in normal subjects. Pulm. Pharmacol. 3:1990;151-154.
2. 2 gradient in man. Proc. Soc. Exp. Med. Biol. 84:1953;193-195.
3. Bickler P.E., Litt L., Banville D., Severinghaus J.W. Effects of acetazolamide on cerebral acid-base balance. J. Appl. Physiol. 65:1988;422-427.
4. Boudewyns A., Willemen M., Wagemans M., De Cock W., Van de Heyning P., De Backer W. Assessment of respiratory effort by means of strain gauges and esophageal pressure swings: a comparative study. Sleep. 20:1997;168-170.
5. Cain S.A., Otis A.B. Carbon dioxide transport in anesthetized dogs during inhibition of carbonic anhydrase. J. Appl. Physiol. 16:1961;1023-1028.
6. 2. J. Physiol. (London). 441:1991;433-451.
7. De Backer W.A. Central sleep apnoea, pathogenesis and treatment: an overview and perspective. Eur. Respir. J. 8:1995;1372-1383.
8. De Backer W.A., Verbraecken J., Willemen M., Wittesaele W., De Cock W., Van de Heyning P. Central apnea index decreases after prolonged treatment with acetazolamide. Am. J. Respir. Crit. Care Med. 151:1995;87-91.
9. CO2 during prolonged acetazolamide treatment in humans. Am. J. Physiol. 258:1990;954-959.
10. Hirahara K., Taki K., Tomita S., Yamada T. Acetazolamide-induced inhibition of carbonic anhydrase influences energy metabolism and respiratory work in healthy subjects. Res. Commun. Mol. Pathol. Pharmacol. 90:1995;125-131.
11. Hommura F., Nishimura M., Oguri M., Makita H., Hosokawa K., Saito H., Miryamoto K., Kawakami Y. Continuous versus bilevel positive airway pressure in a patient with idiopathic central sleep apnea. Am. J. Respir. Crit. Care Med. 155:1997;1482-1485.
12. Issa F.G., Sullivan C. Reversal of central sleep apnea using nasal CPAP. Chest. 90:1986;165-171.
13. Konig S.A., Offner B., Czachurski J., Seller H. Effects of inhibitors of enzymatic and cellular pH-regulating systems on central sympathetic chemosensitivity. Pfügers Arch. 430:1995;690-696.
14. Lassen N.A. Is central chemoreceptor sensitive to intracellular rather than extracellular pH? Clin. Physiol. 10:1990;311-319.
15. Longobardo G.S., Gothe B., Goldman M.D., Cherniack N.S. Sleep apnea considered as a control system instability. Respir. Physiol. 50:1982;311-333.
16. Read D. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann. Med. 16:1967;20-32.
17. Rechtschaffen, A., Kales, A., 1968. A manual of standardised terminology, techniques and scoring for sleep stages of human subjects. Brain Information Service/Brain Research Institute. University of California at UCLA. Los Angeles.
18. Staats B.A., Bonekat H.W., Harris C.D., Offord K.P. Chest wall motion in sleep apnea. Am. Rev. Respir. Dis. 130:1984;59-63.
19. Stradling J.R., Crosby J.H. Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax. 46:1991;85-90.
20. Swenson E.R., leatham K.L., Roach R.C., Schoene R.B., Mills W.J., Hackett P.H. Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing. Respir. Physiol. 86:1991;333-343.
21. Swenson E.R., Hughes J.M. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J. Appl. Physiol. 74:1993;230-237.
22. Swenson E.R., Graham M.M., Hlastala M.P. Acetazolamide slows VA/P matching after changes in regional blood flow. J. Appl. Physiol. 78:1995;1312-1318.
23. 2 and on ventilation in peripherally chemodenervated cats. Pflügers Arch. 415:1990;519-525.
24. Tojima H., Kunitomo F., Kimura H., Tatsumi K., Kuriyama T., Honda Y. Effects of acetazolamide in patients with sleep apnoea syndrome. Thorax. 43:1988;113-119.
25. Vorstrup S., Henriksen L., Paulson O.B. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J. Clin. Invest. 74:1984;1634-1639.
26. Warner G., Skatrud J.B., Dempsey J. Effect of hypoxia-induced periodic breathing on upper airway obstruction during sleep. J. Appl. Physiol. 62:1987;2201-2211.
27. White D.P., Zwillich C.W., Pickett C.K., Douglas N.J., Findley L.J., Weil J.V. Central sleep apnea. Improvement with acetazolamide. Arch. Intern Med. 142:1982;1816-1819.
28. Whyte K.F., Gould G.A., Airlie M.A., Shapiro C.M., Douglas N.J. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep. 11:1988;463-472.
29. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328:1993;1230-1235.